Feeding difficulties, poor weight gain, and hypoglycemia frequently seen in human patients may be countered by targeted manipulation of genetic targets and pathways affiliated with HMGA2-induced adipocyte formation. The gene discussed is HMGA2; the disease is Hypoglycemia.